Grand River Aseptic Manufacturing (GRAM), a parenteral contract development and manufacturing organization (CDMO), was recently ranked in Inc. Magazine’s Inc. 5000 list for the third consecutive year.
 
Evaluated according to the percentage growth of annual revenue over a three-year period, this global and national recognition celebrates GRAM’s business productivity, rapid revenue growth and ongoing customer-base expansion.
 
“It is an incredible honor to have Grand River Aseptic Manufacturing recognized on the Inc. 5000 list for the third year in a row,” said Tom Ross, chief executive officer, GRAM. “We take great pride in our team’s technical excellence and commitment to quality in the work we do.”
 
GRAM produces parenteral therapeutics to various clients from clinical trials to commercialization. Expected to open in 2020, GRAM’s third facility will enable the manufacturer to continue delivering high quality solutions.
 
Recognized as the most prestigious ranking of the nation’s fastest growing private businesses, Inc.’s 36th annual report ranked GRAM #2331 in the country and #34 in the state of Michigan.
 
To view Grand River Aseptic Manufacturing in the full rankings, click here.